ConductScience.org, home

Paper · 19436645

Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis.

Rennenberg RJ and 5 others. Vasc Health Risk Manag, 2009. Cited by 386 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Papers, record 19436645. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19436645

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis.
PubMed
Journal
Vasc Health Risk Manag
PubMed
Year
2009
PubMed
Publication types
Journal Article, Meta-Analysis, Review
PubMed
Citations, by iCite
386
iCite
Relative citation ratio, by iCite
10.8
iCite
Revised in PubMed
2022-03-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rennenberg RJR J M W
2Kessels AGA G H
3Schurgers LJL J
4van Engelshoven JMJ M A
5de Leeuw PWP W
6Kroon AAA A

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CalcinosisMajor topic
Cardiovascular DiseasesMajor topic
Coronary Artery DiseaseMajor topic
Heart Valve DiseasesMajor topic
Peripheral Vascular DiseasesMajor topic
Coronary Disease
Diagnostic Imaging
Humans
Kidney Failure, Chronic
Odds Ratio
Predictive Value of Tests
Reproducibility of Results
Risk Assessment
Risk Factors
Stroke
Time Factors

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115,944,423A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.N Engl J Med2005https://conductscience.org/library/papers/15944423PubMed
215,226,161Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis.Arch Intern Med2004https://conductscience.org/library/papers/15226161PubMed
315,961,706Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification.Arterioscler Thromb Vasc Biol2005https://conductscience.org/library/papers/15961706PubMed
414,722,147Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals.JAMA2004https://conductscience.org/library/papers/14722147PubMed
512,360,172Abdominal aortic calcific deposits are associated with increased risk for congestive heart failure: the Framingham Heart Study.Am Heart J2002https://conductscience.org/library/papers/12360172PubMed
612,958,327Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study.Stroke2003https://conductscience.org/library/papers/12958327PubMed
711,823,653Stroke is associated with coronary calcification as detected by electron-beam CT: the Rotterdam Coronary Calcification Study.Stroke2002https://conductscience.org/library/papers/11823653PubMed
816,449,511Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial.Heart2006https://conductscience.org/library/papers/16449511PubMed
915,992,652Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial.J Am Coll Cardiol2005https://conductscience.org/library/papers/15992652PubMed
1010,694,523Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography.Circulation2000https://conductscience.org/library/papers/10694523PubMed

Cited by220

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 386 citations.

PMIDTitleJournalYearIn PapersSource
42,941,360Association Between Breast Arterial Calcification on Mammography and Carotid Artery Stenosis on CT Angiography: A Retrospective Study in a Selected Cohort of Women Aged 60-65 Years.J Clin Med2026https://conductscience.org/library/papers/42941360PubMed
42,889,018Inverse association between the extracellular matrix protein Tenascin-X and concurrent abdominal aortic calcification in patients with primary aldosteronism.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42889018PubMed
42,754,899Predictive nomogram for abdominal aortic calcification risk: a multi-algorithm approach integrating demographic and clinical variables.J Cardiothorac Surg2026https://conductscience.org/library/papers/42754899PubMed
42,333,862Emerging biomedical and pharmaceutical strategies for the treatment of atherosclerosis: from conventional lipid-lowering therapy to nanomedicine.J Appl Biomed2026https://conductscience.org/library/papers/42333862PubMed
42,315,532Elastin calcification during the initial stage of vascular calcification in kl/kl mice is suppressed by the calcimimetic upacicalcet.Sci Rep2026https://conductscience.org/library/papers/42315532PubMed
42,209,748Review of breast arterial calcifications for cardiovascular disease risk prediction.NPJ Cardiovasc Health2026https://conductscience.org/library/papers/42209748PubMed
42,020,826Adipose-Derived Proinflammatory Visfatin Promotes Vascular Calcification via TLR4 and is Suppressed by Empagliflozin.Inflammation2026https://conductscience.org/library/papers/42020826PubMed
41,903,889Magnesium supplementation did not reduce serum calciprotein crystallization and arterial stiffness in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.Am J Clin Nutr2026https://conductscience.org/library/papers/41903889PubMed
41,772,492Automated opportunistic cardiovascular risk assessment in non-small cell lung cancer patients on routine chest CT using an optimised nnU-net framework.BMC Med Imaging2026https://conductscience.org/library/papers/41772492PubMed
41,593,503Rat models for arterial calcification associated with chronic kidney disease: a systematic review and meta-analysis.BMC Cardiovasc Disord2026https://conductscience.org/library/papers/41593503PubMed

1 to 10 of 220

See all 220 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MGP4,256PubTator's text mininghttps://conductscience.org/library/genes/4256

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19436645

GET https://conductscience.org/api/papers/v1/19436645/references?page=2